Injective breaks above $5.76 on recovery volume – Can INJ clear $6.06?

Injective [$INJ] surged 12.89% in 24 hours to $5.93, breaking out of a week-long consolidation as momentum and trading activity accelerated sharply.

For most of the past week, $INJ remained trapped between the 78.6% Fibonacci support at $5.32 and the 61.8% level at $5.76. That range formed after a sharp correction erased the entire rally from $4.77 to $7.35, producing a near-perfect 100% retracement.

Earlier in the decline, the $5.76 (61.80%) golden pocket failed as support and repeatedly rejected recovery attempts, turning it into the market’s key battleground.

However, that picture has started to change. $INJ has now broken above $5.76 and climbed to roughly $5.95, its highest level in ten days.

This development is notable since AMBCrypto had previously identified the post-Vulcan decline as a “sell the news” correction rather than a structural trend breakdown. More importantly, volume has surged to 342.95K, the strongest reading since the correction began.

That suggests buyers are absorbing supply more aggressively than during previous rebounds. Meanwhile, RSI has climbed to 68.98, its highest level since the June peak.

This signals strengthening momentum, yet it also places $INJ near a zone that previously preceded pullbacks. The next test sits at the 50% Fibonacci level near $6.06. A break above that level would strengthen the recovery momentum and expose $6.74.

However, failure to hold above $5.76 would suggest the breakout lacks conviction, shifting attention back toward $5.32 and potentially the $4.77 low.

What’s next for $INJ?

Attention is now shifting toward the $6.00-$6.06 zone, where the late-May rally previously paused before accelerating higher. That history suggests trapped holders may reintroduce supply as price approaches resistance.

Meanwhile, RSI has climbed to 68.98, nearing levels that preceded reversals during earlier advances. However, this recovery follows a full retracement to $4.77 and a prolonged consolidation phase, creating a different backdrop.

Volume remains the key signal. Sustained strength above $6.06 would indicate demand is absorbing supply. Otherwise, failure to hold $5.76 could return $INJ to consolidation.

Final Summary

• Injective reclaimed the critical $5.76 level on its strongest recovery volume, shifting focus toward resistance at $6.06.
• $INJ recovery remains constructive, though sustained demand is needed to prevent a return to consolidation.